Stay updated with breaking news from Prospective Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RedHill Receives USPTO Notice of Allowance for a Patent Covering Phase 3-stage RHB-204 for the Treatment of NTM Disease - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that...
Palatin Initiates Enrollment in the Phase 2 Bremelanotide BREAKOUT Study in Patients with Diabetic Kidney Disease - read this article along with other careers information, tips and advice on BioSpace
Milwaukee, WI (PRWEB) December 20, 2022 -- AAEA invites media to attend their sessions at the ASSA 2023 Annual Meeting in New Orleans. On Friday, January 6,
Agilent Technologies Inc. announced today that the U.S. Food and Drug Administration has approved Agilent Resolution ctDx FIRST as a companion diagnostic to identify advanced... | December 12, 2022